MissionIR Articles

AmpliPhi Biosciences is a biotech company engaged in the development of anti-bacterial solutions to enhance human health through the application of its proprietary bacteriophage platform. Its lead product development programs target gram negative bacterial infections…

Allied Healthcare Group is a diversified healthcare company focused on investing in next generation technologies, acquiring strategic assets to grow its product and service offerings. BOMDF operates in three businesses: Cordion, focused on vaccine technology…

Aradigm is engaged in developing inhalation drug products designed to improve the quality of life of patients with severe pulmonary disease. The company’s lead development candidates are formulations of the potent antibiotic ciprofloxacin (Pulmaquin (ARD-3150)…

Circadian Technologies is engaged in angiogenesis-based treatments for cancer. Focusing on a class of drug targets called Vascular Endothelial Growth Factors (VEGFs), the company seeks to develop truly novel therapies to extend and improve the…

InVivo Therapeutics is focused on developing and commercializing technologies for the treatment of spinal cord injuries (SCI). The company’s aim is to develop/commercialize biocompatible polymer scaffolding devices to treat acute spinal cord injuries; biocompatible hydrogel…

ImmunoCellular Therapeutics is a clinical-stage biotech company focused on the development of novel immune-based products for the treatment of cancer. The product candidate portfolio includes cellular immunotherapies targeting cancer and cancer stem cell antigens, peptide…

Tvax Biomedical is a clinical stage drug development company advancing its novel targeted cell-based immunotherapy for the treatment of cancer. The company’s lead candidates, focused on treating brain and kidney cancer, are supported by positive…

Atossa Genetics is a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States. Its diagnostic tests include the ForeCYTE Breast…

Repros Therapeutics is a development stage biopharmaceutical company focused on the development of oral small molecule drugs for major unmet medical needs in male and female health. The company’s current product pipeline includes Androxal®, in…

Pressure BioSciences engages in the development and commercialization of pressure cycling technology (PCT), a patented, enabling technology platform with multiple applications in the life sciences sample preparation market. PBIO’s focus is on the development and…

Amarantus Bioscience is a development-stage biotech company focused on the discovery and development of therapeutic proteins and biologics for the treatment of Parkinson’s disease, traumatic brain injury (TBI) and other human diseases. The company owns…

Aethlon Medical is a development stage medical device company focused on creating devices for the treatment of cancer, infectious diseases and other life-threatening conditions. The company’s Aethlon Hemopurifier is intended for the treatment of cancer,…

Medbox, through its subsidiary Prescription Vending Machines Inc., engages in developing a patented machine that dispenses medication to individuals based on biometric identification. The company’s flagship product is MedBox, an automated medicine dispensing machine that…

Amorcyte is a biopharm company engaged in the development of proprietary cellular therapies in cardiovascular disease, immunology and regenerative medicine primarily in the United States. Its lead product candidate, AMR-001, which is for the prevention…

Athersys is a clinical stage biopharm company growing a pipeline of highly differentiated therapeutics to treat significant and life-threatening diseases. The company’s current product development portfolio consists of MultiStem®, a proprietary stem cell product for…

OncoSec Medical is a biotech company focused on the development of treatments addressing advanced-stage skin cancer, specifically: melanoma, Merkel cell lymphoma and cutaneous T-cell lymphoma. ONCS’ proprietary technology, OncoSec Medical System™ (OMS), is based on…

Neuralstem, a development-stage company focused on the development and commercialization of treatments for central nervous system disease, has developed and maintains a portfolio of patents and patent applications that form base for its research and…

ProMetic Life Sciences operates through a group of subsidiaries to specialize in the design of small molecules that mimic unique and specific interactions between proteins. The company’s technologies are applicable to large-scale drug purification, drug…

NovaBay Pharmaceuticals is a clinical-stage biotech company focused on the development of its proprietary and patented Aganocide® compounds. NBY focuses its technology on four therapeutic areas: dermatology, ophthalmology, urology and hospital infections. The company has…

Shire is a biopharmaceutical company that focuses its business on attention deficit hyperactivity disorder, human genetic therapies, gastrointestinal diseases and regenerative medicine as well as opportunities in other therapeutic areas. SHPG’s in-licensing, merger and acquisition…

Organovo Holdings focuses on breakthrough 3D biology capabilities to create tissue on-demand for research and surgical applications. The company’s NovoGen MMX Bioprinter™ is the world’s only commercial bioprinter with the proven ability to create tissue.…

Resverlogix is a clinical stage cardiovascular company with an epigenetic platform technology that modulates protein production. The company is developing RVX-208 for the treatment of atherosclerosis. RVX’s business model is to seek strategic opportunities through…